BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11733971)

  • 1. Mitotic index and ki-67 nuclear antigen labeling index as predictors of chemotherapy response in uterine cervical carcinoma.
    Kamoi S; Ohaki Y; Okada S; Matsushita N; Kawamura T; Araki T
    Gynecol Oncol; 2001 Dec; 83(3):555-9. PubMed ID: 11733971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment mitotic index versus computer-quantitated Ki-67 nuclear antigen labeling index as predictors of response to neoadjuvant chemotherapy in uterine cervical carcinoma.
    Kamoi S; Ohaki Y; Amano Y; Mori O; Matsushita N; Doi D; Okada S; Sugisaki Y; Kawamura T; Araki T
    J Nippon Med Sch; 2003 Jun; 70(3):219-26. PubMed ID: 12928723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A ratio of apoptosis to mitosis, proliferation pattern and prediction of radiotherapy response in cervical carcinoma.
    Gasinska A; Urbanski K; Gruchala A; Biesaga B; Kojs Z
    Neoplasma; 2002; 49(6):379-86. PubMed ID: 12584585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy in cervical carcinoma: regulators of cell cycle, apoptosis, and proliferation as determinants of response to therapy and disease outcome.
    Costa S; Terzano P; Santini D; Ceccarelli C; Martoni A; Angelelli B; Panetta A; Bovicelli A; Cristiani P; Lipponen P; Erzén M; Syrjänen S; Syrjänen K
    Am J Clin Pathol; 2001 Nov; 116(5):729-37. PubMed ID: 11710691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic p105 index is an accurate mitotic index, but is not related to prognosis in cervical carcinoma.
    Oka K; Nakano T; Arai T
    Arch Pathol Lab Med; 1994 May; 118(5):506-9. PubMed ID: 7910727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy.
    Kim BG; Kim JH; Park SY; Lee JH; Lee ED; Lee KH; Park KB; Lee BH; Kim KH
    Gynecol Oncol; 1996 Oct; 63(1):105-13. PubMed ID: 8898178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some kinetic characteristics of cervical cancer].
    Zharinov GM; Pozharisskiĭ KM; Vinokurov VL; Neklasova NIu; Mironovskaia NV; Kuznetsova ME; Tarkova AB
    Vopr Onkol; 2009; 55(2):196-200. PubMed ID: 19514375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Ki-67 proliferation and apoptotic index before, during and after neoadjuvant chemotherapy for primary breast cancer.
    Burcombe R; Wilson GD; Dowsett M; Khan I; Richman PI; Daley F; Detre S; Makris A
    Breast Cancer Res; 2006; 8(3):R31. PubMed ID: 16790076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.
    Penault-Llorca F; Abrial C; Raoelfils I; Chollet P; Cayre A; Mouret-Reynier MA; Thivat E; Mishellany F; Gimbergues P; Durando X
    Oncologist; 2008 Dec; 13(12):1235-45. PubMed ID: 19091781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neoadjuvant chemotherapy before radiotherapy in treatment of patients with cervical carcinoma].
    Li QS; Zhang XQ; Li DP; Sheng XG; Du XL; Song QQ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):83-7. PubMed ID: 16640853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of glassy cell carcinoma of the uterine cervix that responded to neoadjuvant chemotherapy with paclitaxel and carboplatin.
    Takekuma M; Hirashima Y; Takahashi N; Yamamichi G; Furukawa N; Yamada Y; Takakuwa R; Ito I
    Anticancer Drugs; 2006 Jul; 17(6):715-8. PubMed ID: 16917218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
    Choi CH; Song SY; Choi JJ; Park YA; Kang H; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
    BMC Cancer; 2008 Oct; 8():295. PubMed ID: 18847499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer.
    Maneo A; Chiari S; Bonazzi C; Mangioni C
    Gynecol Oncol; 2008 Dec; 111(3):438-43. PubMed ID: 18835493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of mitotic index of proliferating cell populations in cervical cancer patients treated with carbon ion beam.
    Suzuki Y; Oka K; Ohno T; Kato S; Tsujii H; Nakano T
    Cancer; 2009 May; 115(9):1875-82. PubMed ID: 19224551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of tumor growth index with early treatment response in cervical carcinoma.
    Trejo-Becerril C; Rivera L; Chanona J; Segura B; Pérez E; López-Graniel C; Hinojosa-García L; Dueñas-González A
    J Exp Clin Cancer Res; 2002 Mar; 21(1):57-63. PubMed ID: 12071531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High growth fraction at 9 grays of radiotherapy is associated with a good prognosis for patients with cervical squamous cell carcinoma.
    Oka K; Suzuki Y; Nakano T
    Cancer; 2000 Oct; 89(7):1526-31. PubMed ID: 11013367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
    Ferrandina G; Macchia G; Legge F; Deodato F; Forni F; Digesù C; Carone V; Morganti AG; Scambia G
    Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ki-67 expression as a predictor of the effectiveness of radiotherapy and of outcome in locally advanced squamous cell carcinoma of the uterine cervix (immunohistochemical study)].
    Kuznetsova ME; Pozharisskiĭ KM; Vinokurova VL; Zharinov GM; Neklasova NIu
    Vopr Onkol; 2007; 53(2):175-80. PubMed ID: 17663171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.